Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Grant/Award of 100,000 CTMX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 100,000 | n/a |
| Jan 6, 2026 | Mersana Therapeutics, Inc. (MRSN) | Tender of Shares | 3,131 | n/a |
| Jan 18, 2025 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 12,500 | n/a |
| Jan 16, 2025 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 2,500 | n/a |
| Jan 16, 2025 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 8,958 | n/a |
| Oct 7, 2024 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 50,000 | n/a |
| Jan 17, 2024 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 8,958 | n/a |
| Sep 7, 2023 | Mersana Therapeutics, Inc. (MRSN) | Grant/Award | 50,000 | n/a |
| Apr 28, 2023 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 13,250 | n/a |
| Jan 19, 2023 | Mersana Therapeutics, Inc. (MRSN) | Exercise/Conversion | 2,500 | n/a |